PGC-1β modulates statin-associated myotoxicity in mice

Show full item record



Permalink

http://hdl.handle.net/10138/298684

Citation

Singh , F , Zoll , J , Duthaler , U , Charles , AL , Panajatovic , M V , Laverny , G , McWilliams , T , Metzger , D , Geny , B , Krähenbühl , S & Bouitbir , J 2019 , ' PGC-1β modulates statin-associated myotoxicity in mice ' , Archives of Toxicology , vol. 93 , no. 2 , pp. 487–504 . https://doi.org/10.1007/s00204-018-2369-7

Title: PGC-1β modulates statin-associated myotoxicity in mice
Author: Singh, François; Zoll, Joffrey; Duthaler, Urs; Charles, Anne‑Laure; Panajatovic, Miljenko V.; Laverny, Gilles; McWilliams, Thomas; Metzger, Daniel; Geny, Bernard; Krähenbühl, Stephan; Bouitbir, Jamal
Contributor: University of Helsinki, Research Programme for Molecular Neurology
Date: 2019-02
Language: eng
Number of pages: 18
Belongs to series: Archives of Toxicology
ISSN: 0340-5761
URI: http://hdl.handle.net/10138/298684
Abstract: Statins inhibit cholesterol biosynthesis and lower serum LDL-cholesterol levels. Statins are generally well tolerated, but can be associated with potentially life-threatening myopathy of unknown mechanism. We have shown previously that statins impair PGC-1β expression in human and rat skeletal muscle, suggesting that PGC-1β may play a role in statininduced myopathy. PGC-1β is a transcriptional co-regulator controlling the expression of important genes in mitochondrial biogenesis, antioxidative capacity and energy metabolism. The principle aim of the current study was to investigate the interaction between atorvastatin and PGC-1β in more detail. We therefore treated wild-type mice and mice with selective skeletal muscle knockout of PGC-1β (PGC-1β(i)skm−/− mice) with oral atorvastatin (5 mg/kg/day) for 2 weeks. At the end of treatment, we determined body parameters, muscle function, structure, and composition as well as the function of muscle mitochondria, mitochondrial biogenesis and activation of apoptotic pathways. In wild-type mice, atorvastatin selectively impaired mitochondrial function in glycolytic muscle and caused a conversion of oxidative type IIA to glycolytic type IIB myofibers. Conversely, in oxidative muscle of wild-type mice, atorvastatin enhanced mitochondrial function via activation of mitochondrial biogenesis pathways and decreased apoptosis. In PGC-1β(i)skm−/− mice, atorvastatin induced a switch towards glycolytic fibers, caused mitochondrial dysfunction, increased mitochondrial ROS production, impaired mitochondrial proliferation and induced apoptosis in both glycolytic and oxidative skeletal muscle. Our work reveals that atorvastatin mainly affects glycolytic muscle in wild-type mice and demonstrates the importance of PGC-1β for oxidative muscle integrity during long-term exposure to a myotoxic agent.
Subject: 1182 Biochemistry, cell and molecular biology
Atorvastatin
Reactive oxygen species
· Myopathy ·
PGC-1β
Apoptosis
(ROS) · Mitochondrial proliferation
1184 Genetics, developmental biology, physiology
3111 Biomedicine
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Singh2019_Artic ... dulatesStatin_associat.pdf 6.353Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record